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ABSTRACT

Immunologic memory is the ability of the immune system to generate an enhanced
antibody response against previously encountered antigens. The clonal selection theory
of acquired immunity attributes immunologic memory to the formation of an expanded
compartment of quiescent antigen-specific memory B cells that are capable of rapid
activation upon secondary antigen encounter. Whereas protein antigens are known to
elicit memory B cells, it is not known whether polysaccharide antigens do.
Here we report that polysaccharide antigens elicit memory B cells that are
phenotypically distinct from those elicited by protein antigens. We show that antigen
affinity of the B cell receptor regulates the development of memory B cells and that
antigen-specific IgG antibodies suppress recall responses against polysaccharides via a
mechanism that does not depend on epitope masking or involve known Fey receptors.
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INTRODUCTION

Vaccination and Theories of Acquired Immunity
It has been known since ancient times that humans who recover from an infectious

disease, such as smallpox, are spared when the epidemics returns. This resistance

reinfection was termed immunity from the Latin word immunitas, which originally m

the exemption from service to the state. In the early 18th century the practice o

variolation became popular in England as a prophylactic measure against smallpox.
involved inoculation of a healthy individual with a virus from smallpox pustules

infected person to elicit a less severe disease. At the end of the 18th century E

Jenner introduced vaccination, a safer method of smallpox prevention by inoculati

humans with vaccinia, a virus derived from cowpox pustules. A century later Louis

Pasteur made a similar discovery that chickens that had recovered from mild chole

induced by an attenuated strain were resistant to subsequent challenge with a mor

virulent strain. This generalization of the Jennerian principle laid the foundati
science of Immunology.
At the end of the 19th century, Emil von Behring and Shibasaburo Kitasato
reported that animals immunized with diphtheria or tetanus toxin produced some

substance in their blood (named anti-toxin) that could neutralize the toxin and p

disease. As a practical application of this finding, anti-sera obtained from expe

animals were used to cure diphtheria and tetanus in humans. Thus, anti-toxin (late

renamed antibody) became one of the earliest recognized agents of acquired immuni
against pathogenic antigens.

In the first half of the 20th century various theories were proposed to account for
antibody formation, the earliest being the side-chain theory of Paul Ehrlich. He argued
that bacterial toxins bind to complementary chemical patterns (side-chains) that are
normally responsible for some metabolic function in the cell. To overcome the metabolic
block, cells shed off and then regenerate their side-chains, which accumulate in the
bloodstream. It soon became apparent that antibodies could form not only against a

handful of bacterial toxins but virtually against any natural or artificial antigen, excep
self-antigens, and it started to appear unlikely that such an enormous repertoire of
complementary side-chains could exist, as the theory predicted.
The side-chain theory was succeeded by the direct template theory, which
attempted to explain antibody formation without postulating the enormous pre-existing
diversity of recognition patterns. According to this theory, an antigen itself determines
antibody specificity by entering a cell and serving as a template for antibody folding.
This theory had to be abandoned after the discovery that it is the primary sequence of a

protein that specifies its folding pattern. To accommodate this finding and to account for
the persistence of antibody production, the indirect-template theory was proposed.
According to this theory, a "genocopy" of an antigen incorporates into the genome of a
cell, which allows it to specify the folding pattern of the antibody and to direct its
production in descendant cells that have inherited the "genocopy".
A novel way of thinking about acquired immunity was inspired by Jerne's natural
selection theory. Jerne proposed that immunoglobulins normally present in the serum
carry reactive sites to any antigenic determinant, except those found in the body. An
external antigen entering the body is responsible for selective carrying of a particular

immunoglobulin to the system of cells that can produce the same type of immunoglobulin
in large quantities. Jerne's natural selection theory served as a precursor for Burnet's
clonal selection theory, which postulated the cellular basis of humoral immunity. The
hallmarks of the clonal selection theory are antigen-independent diversity achieved by
means of somatic randomization and antigen-dependent selection resulting in preferential
expansion of clones of a particular antigen specificity (Burnet, 1959). The main
predictions of the theory are:

1) existence of a diverse repertoire of lymphocytic cells each carrying antigenbinding sites of a single specificity;
2) establishment of self-tolerance due to elimination of cells carrying self-reactive
sites; and
3) clonal selection achieved by antigen-driven expansion of cells carrying antigenspecific sites with further selection of mutants with increased antigen affinity.

Subsequent studies in the second half of the 20th century have validated the clonal
selection theory and elucidated cellular and molecular mechanisms responsible for the
postulated features of the immune system.

B Cell Activation by T-Independent T y p e II Antigens
B lymphocytes (B cells) carry a membrane-bound form of antibody of a single antigen
specificity called the B cell receptor (BCR), which consists of a pair of heavy and light
chains. During the development in the bone marrow, B cell precursors undergo a
stepwise assembly of their BCRs to generate the peripheral pool of mature B cells with a
diverse repertoire of antigen specificities but limited self-reactivity. Upon antigen
contact, mature B cells undergo activation and give rise to antibody-secreting plasma
cells and quiescent memory B cells.

Characteristics of T-I type II antigens
Unlike soluble protein antigens, which are not capable of inducing antibody responses in
athymic (nude) mice, some antigens are immunogenic in these animals and have been
therefore called thymus-independent (T-I). They are further divided into type I and type

II, according to their ability or inability to elicit antibody responses in CB A/N (Xid) m

(Mond et al, 1995). T-I type I antigens include products of bacterial or viral origin, such
as LPS, CpG, poly-IC, etc., which activate B cells polyclonally via Toll-like receptors.
On the other hand, T-I type II antigens such as polysaccharides and polymeric proteins
engage BCRs and thus induce antigen-specific B cell responses. Typical T-I type II
antigens include negatively charged or neutral capsular polysaccharides produced by
some bacteria, such as S. pneumoniae, as well as synthetic haptenated polysaccharides,
such as 4-hydroxy-3-nitrophenylacetyl (NP)-Ficoll.
The characteristics of T-I type II antigens are large molecular weight, high

epitope valence (Dintzis et al, 1989), and poor degradability in vivo (Britton et al, 1968;

Sela et al, 1972). Radioactive labeling revealed that m a n y polysaccharides are retained
in the liver and the spleen with an average half-life of more than 30 days (63 days for
Ficoll) in mice (Humphrey, 1981).
Neutral and negatively charged polysaccharides do not bind to MHC class II
molecules (Harding et al, 1991). However, zwitterionic polysaccharides, synthesized by
B. fragilis and 5. aureus, can be processed to low molecular weight carbohydrates by a
nitric oxide-mediated mechanism and due to their ability to form a-helixes can be loaded
on MHC class II molecules and stimulate proliferation of CD4+ T cells (Kalka-Moll et
al, 2002; Cobb et al, 2004).

BCR signaling
By systematically varying the number and spacing of dinitrophenol (DNP) haptens on
polyacrylamide (a T-I type II carrier), Dintzis et al. found that immunogenic preparations
had a threshold number (of approximately 20 or more) of appropriately spaced (5-10 nm
apart) repeating epitopes. Molecules with less than this number of haptens were not
immunogenic at any dose (Dintzis et al, 1976; Dintzis et al, 1983). These studies,
extended to other T-I type II carriers such as dextran and Ficoll (Dintzis et al, 1989),
suggested that multiple BCRs must be aggregated on the B cell surface by a T-I type II
antigen to elicit B cell activation.
BCR crosslinking induces a complex signaling cascade. As the cytoplasmic
domains of the heavy chains of the BCR are very short, BCR signaling is propagated
through the cytoplasmic domains of non-covalently associated Iga, and IgfJ subunits, both
possessing immunoreceptor tyrosine-based activation motifs (ITAMs) (Flaswinkel and

Reth, 1994). Aggregation of B C R complexes upon antigen binding causes their
translocation to lipid rafts in the plasma membrane and facilitates tyrosine
phosphorylation of ITAMs of Iga/IgP by a src-family protein tyrosine kinase (PTK) Lyn
and possibly other PTKs enriched in these microdomains (Cheng et al, 1999).
Phosphorylated ITAMs of Iga/IgP then recruit and activate a cytosolic PTK Syk (Rowley
et al, 1995). This initial stage of BCR triggering is modulated by Csk, which
phosphorylates the C-terminal inhibitory tyrosine of src-family kinases (Hata et al,
1994). Acting in opposition to Csk is a transmembrane tyrosine phosphatase CD45
(B220), which dephosphorylates the inhibitory tyrosine of src-family kinases (Pao et al,
1997) to ensure that they are in a state responsive to activation by BCR aggregation.
Thus, the balance between the Csk and B220 activities regulates B cell responsiveness to
BCR triggering.
Proper BCR signal transduction requires ordered activation of PTKs Lyn, Syk,
and Btk. A crucial requirement for Btk function is its recruitment to the plasma
membrane via the binding of its PH domain to PIP3 generated by PI-3K phosphorylation
of a plasma membrane lipid PIP2 (Gold et al, 1992; Saito et al, 2001). Although a
defect in the Btk's PH domain, such as the one found in Xid mice, does not abolish B cell

activation and proliferation, it renders B cells activated by T-I type II antigens suscept
to apoptosis (Vinuesa et al, 2001). Btk defects in humans lead to X-linked
agammaglobulinemia (XLA) (Thomas etal, 1993).
Activation of Syk and Btk leads to BLNK-dependent recruitment and activation
of PLCy2 (Fu etal, 1998), which can cleave PIP2 into secondary messengers, IP3 and
DAG. IP3 generation stimulates increased Ca2+ influx into the cytoplasm leading to

activation of Ca2+-dependent transcription factors (Dolmetsch et al., 1997). D A G is
required for activation of PKCp\ which is essential for phosphorylation of IKKa and
subsequent activation of NF-kB (Saijo et al, 2002). As is the case with Btk, activation of
PKCp is crucial for T-I type II antibody responses (Leitges et al, 1996).
CD22 and FcyRIIB are known negative regulators of BCR signaling (Lankester et
al., 1995; Ono et al, 1996). CD22 regulates Ca2+ efflux by plasma membrane calciumATPase-4 (PMCA-4) in SHP-1 dependent manner (Chen et al, 2004). FcyRIIBmediated inhibition is dependent on the inositol phosphatase SHIP, which
dephosphorylates PIP3 and thus reduces the levels of membrane-associated Btk (Ono et
al., 1996; Bolland et ah, 1998). Internalization of the BCR complex might also be a
potent regulator of BCR signaling, since impaired BCR internalization in B cells with a
mutated Ig|3Y2A chain correlates with augmented T-I type II antibody responses in vivo
(Gazumyan et al, in press).

T-Independent T y p e II Antibody Responses
Splenic architecture and subpopulations of peripheral B cells
Immune responses take place in secondary lymphoid organs, such as the spleen, lymph
nodes, and tissues associated with mucosal and gastro-intestinal surfaces. The spleen is
the largest lymphoid organ containing 25% of mature lymphocytes. It is organized into

two major areas: the red and the white pulp. The red pulp, the site of elimination of aged
erythrocytes, also contains macrophages and plasma cells. The white pulp compartment
contains mature B and T lymphocytes segregated from each other. A central T-cell rich
zone, called periarteriolar lymphoid sheath (PALS), is surrounded by B cell-rich primary
follicles, each containing a network of follicular dendritic cells (FDCs). The marginal
sinus, lined with metallophilic macrophages, separates the white pulp from the red pulp,
which are connected via the bridging channels containing CD1 lchlghDEC205" dendritic
cells (DCs) (Figure 1; reviewed in Fu and Chaplin, 1999).
B cells are organized into two compartments in the white pulp: primary follicles
and the marginal zone (MZ). MZ B cells comprise about 10-15% of splenic B cells and
are located on both sides of the marginal sinus. The MZ B cell compartment appears late
in ontogeny and is indispensable for T-I type II immune responses. Factors responsible
for cell adhesion are required for its formation, since interference with integrins, such
LFA-1 and its ligands ICAM-1 and VCAM-1, prevents B cell retention in the marginal
zone (Lu and Cyster, 2002). Disruption of Pyk-2 kinase, a downstream component of
integrin signaling, also results in the loss of the MZ B cell compartment (Guinamard et
al, 2000).

Figure 1. Structure of the white pulp nodule in the spleen.

Surrounding the central arteriole (CA) is a T cell-rich area called periarteriolar
lymphoid sheath (PALS). Adjacent to PALS are B cell-rich primary follicles that
include follicular dendritic cells (FDCs). The white pulp is separated from the red
pulp (RP) by the bridging channels (BC) and the marginal sinus (MS), which is
embedded in a layer of marginal zone (MZ) B cells. (Adapted from Fu and
Chaplin, 1999).

RP
Primary
Follicle'

In addition to conventional B cells (follicular and M Z B cells), peripheral B cells
include B-l cells occupying primarily peritoneal and pleural cavities. B-l cells form a
self-renewing population that can get activated and differentiate to plasma cells without

exposure to external antigens. B-l cells have a limited repertoire of specificities and ar
thought to be the source of natural weakly auto-reactive antibodies normally found in the
serum (Martin and Kearney, 2001).

Antigen localization in the spleen
Blood-borne antigens gain rapid access to the spleen. The blood enters the spleen
through the splenic artery, which branches into trabecular arteries, and ultimately into
central arterioles, which penetrate the white pulp nodules. Within minutes after
intravenous injection, polysaccharides can be detected in the splenic marginal zone
(Eertwegh et al, 1992). Blood-borne bacteria are captured and carried to the splenic
marginal zone by neutrophils and blood DCs (Balazs et al, 2002).
Polysaccharide antigens are retained both in B cell follicles on FDCs and in
extrafollicular regions on macrophages. The majority of the polysaccharide load is
associated with the latter and is normally limited on the former. Follicular localization
polysaccharide antigens is dependent on complement and can be abrogated by cobra
venom factor (CVF)-induced complement depletion. In contrast, macrophage depletion
results in loss of polysaccharide accumulation in the marginal zone and the red pulp with
concomitant increase in follicular localization (Eertwegh et al, 1992).
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G C reaction and extrafollicular response to T-I type II antigens
B cells that have been triggered by antigen initiate the germinal center (GC) reaction

within B cell follicles or proliferate in extrafollicular foci, such as the bridging chann
and the red pulp. Although the GC reaction is usually associated with T-D responses,
GCs induced by T-I type II antigens have also been described, originally for
a(l->6)dextran (Wang et al., 1994). In wild-type mice, polysaccharide-induced GCs do
not contain T cells (Vinuesa et al, 2000) and can form in T cell-deficient mice (Lentz
and Manser, 2001). T-I GCs are short-lived and support very low levels of somatic
mutation of immunoglobulin V regions (Toellner et al, 2002). Their functional
significance is unknown.
T-I type II responses support class switch recombination, primarily to IgG3
isotype. The Cy3 transcript can be detected as early as day 1 and IgG antibodies appear
in the serum by day 6 after NP-Ficoll immunization (Vinuesa et al, 1999). The
expression of activation-induced cytidine deaminase (AID), an enzyme required for
somatic hypermutation and class switch recombination (Muramatsu et al., 2000), has
been analyzed in human lymphoid tissues, where it has been detected both in GC blasts
and in extrafollicular large proliferating B cells (Cattoretti et al, 2006).
During the extrafollicular response, activated B cells proliferate as plasmablasts in
physical proximity to CD1 lchigh DEC205" DCs (Vinuesa et al, 1999) and require
BAFF/APRIL to sustain their survival (Balazs et al, 2002). Plasmablasts exit the cell

cycle and terminally differentiate to plasma cells, which increase antibody secretion. The
exit from the cell cycle requires a CDK6 inhibitor pl8INK4c (Tourigny et al, 2002), whose
expression increases in response to IL-6 (Morse et al, 1997).
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Molecular requirements for plasma cell development
Differentiation to plasma cells and maintenance of the plasma cell fate are under the
control of a transcription factor Blimp-1 (Shapiro-Shelef et al, 2003; Shapiro-Shelef et
al, 2005). Through direct and indirect interactions, Blimp-1 represses genes involved in
maintaining B cell fate (e.g. Pax-5), proliferation (e.g. c-myc and E2F1), and the GC
function (e.g. AID, Stat6, DNA-PK, Ku70, and Ku80) (reviewed in Shapiro-Shelef and
Calame, 2005). By down-regulating a B cell transcription factor Pax-5, Blimp-1 causes
down-regulation of Pax-5-dependent genes, such as CD19, Iga, syk, and BLNK, and upregulation of genes repressed by Pax-5, such as XBP-1, which in turn induces the
expression of a large set of genes whose products participate in the expansion of the
endoplasmic reticulum (ER) and in protein trafficking (Shaffer et al, 2004). To be
translated into a functional protein, XBP-1 mRNA must be processed by IRE la, an ER
membrane-associated enzyme activated by the unfolded protein response (UPR) (Calfon
et al, 2002; Iwakoshi et al, 2003). The UPR regulates the protein folding capacity of the
ER and results in the remodeling of the secretory pathway during the physiologic
transition from a non-secretory to secretory cell type or during pharmacologically
induced ER stress.
Blimp-1 expression can be directly repressed by Bcl-6 via a conserved Bcl-6
response element found in the intronic region of the prdm-1 gene encoding Blimp-1
(Tunyaplin et al, 2004). Although transcribed in naive B cells, high levels of the Bcl-6
protein accumulate in GC B cells (Fukuda et al, 1997), in which Blimp-1 expression is
restricted to a minor subset of Bcl-6" cells (Angelin-Duclos et al, 2000). In GC B cells,
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Bcl-6 is co-expressed with its cofactor M T A 3 , which is required for Bcl-6 acetylation and
efficient suppression of Blimp-1 (Fujita et al., 2004).
IRF4 is another transcription factor necessary for plasma cell development. Irf4~'~
mice lack serum immunoglobulin and fail to be activated and proliferate in response to
LPS ex vivo (Mittrucker et al, 1997). Ectopic expression of the IRF4 transcriptional
antagonist MITF leads to the same defect, whereas Mitf' B cells express higher levels of
IRF4 and spontaneously differentiate into plasma cells (Lin et al, 2004). Thus, IRF4
might be required earlier than Blimp-1 in the sequence of events leading to plasma cell
production.

Plasma cell survival and apoptosis

Terminally differentiated plasma cells reside both in the splenic red pulp and in the bone
marrow. The longevity of plasma cells had been debated. The lifespan of the majority of
plasma cells in the lymph nodes and the spleen was estimated to be less than 3 days;
however, plasma cells residing in the bone marrow and a small fraction of splenic plasma
cells had a lifespan in excess of 3 weeks (Ho et al., 1986) and some could be detected by
autoradiography through the 6th month time point (Miller, 1964). Recently, the half-life
of lymphocytic choriomeningitis virus (LCMV)-specific plasma cells in LCMV-infected
mice was estimated to be approximately 170 days in the spleen and 90 days in the bone
marrow (Slifka et al, 1998). However, these studies focused on the plasma cell
compartment established two weeks after the infection and did not rule out that plasma
cells formed early during the immune response to the virus were short-lived.
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Factors that determine the lifespan of plasma cells are not completely understood.

Early plasma cell death is attributed to the finite capacity of the spleen to sustain them
No more than 20-100 plasma cells per mm2 of spleen sections could be detected beyond
day 7 after T-D or T-I type II immunization, irrespective of the number of B cells
recruited into the response or the number of plasma cells produced before day 7 (Sze et
al, 2000). Plasma cells express death receptors DR4 and DR5 together with their ligand
TRAIL and, unlike naive or activated B cells, are sensitive to TRAIL-induced apoptosis
ex vivo (Ursini-Siegel et al, 2002).
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Feedback Regulation of Antibody Responses
Immune complexes (ICs) modulate B cell responses by co-ligating the BCR and the
inhibitory Fc receptor FcyRIIB on B cells. Fc receptors are also present on non-lymphoid
cells, such as macrophages, DCs, and FDCs, thereby affecting antibody responses by
regulating antigen localization and persistence.

Fc receptors
Antibody responses are modulated through the action of activating and inhibitory
receptors. Fey receptors, ligated by Fc portions of IgG molecules, belong to both
categories. Similar to Iga and Igp\ some activating Fey receptors contain ITAMs in their
intracellular domains (e.g. human FcyRIIA) or are associated with the ITAM-containing
FcRy chain (e.g. human and murine FcyRI and FcyRIII) (Ravetch and Bolland, 2001).
Inhibitory receptors contain cytoplasmic immunoreceptor tyrosine-based
inhibitory motifs (ITIMs). The only known inhibitory Fey receptor is FcyRIIB (Muta et
al, 1994). Targeted disruption of FcyRIIB results in disregulation of the immune system
leading to augmented anaphylactic responses and spontaneous strain-dependent
autoimmune phenotype (Takai et al, 1996). Similarly, human patients with
polymorphisms in the FcyRIIB promoter that lead to lower levels of FcyRIIB expression
are prone to autoimmunity (Su et al, 2004). IgG-containing ICs are crucial for the
development of autoimmune symptoms, and FcyRIIB disruption leads to preferential
augmentation of IgG titers, evident in the B6.56R anti-DNA BCR murine model
(Fukuyama et al, 2005).
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In addition to its role in inhibitory signaling and modulation of autoimmunity,
FcyRIIB is involved in trapping ICs on the surface of non-phagocytic FDCs and in the
recycling of endocytosed ICs by phagocytic antigen-presenting cells, such as DCs.
Unlike activating Fey receptors, FcyRIIB accesses a non-degradative vesicular
compartment that recycles to the cell surface and preserves the associated antigen in its
native form (Bergtold et al, 2005).
B cells express FcyRIIB but not any known activating Fey receptors. A few Fc
receptor homologs have been identified through the homology search of genome
databases (Davis et al., 2002) and two of them, FcRHl and FcRH3, are expressed on
murine B cells (Davis et al, 2004). In addition, a high affinity Fc receptor for IgA and
IgM (Fca/pR) has been identified on B cells as well as on non-lymphoid cells. This
receptor acquires the ability to bind IgM upon B cell activation and can mediate
endocytosis of IgM-coated bacteria (Shibuya et al, 2000; Sakamoto et al, 2001). The
functions of these novel Fc receptors remain to be determined.

IgG-mediated enhancement of T-D responses
Formation of IgG-containing ICs with soluble protein antigens has an enhancing effect on
T-D antibody responses (Heyman, 2003). This effect is mediated by IgG[, IgG2a, and
IgG2b and is independent of complement (Wiersma et al, 1990). IgG-mediated
enhancement is impaired in FcRy chain-deficient mice (Wernersson et al, 1999).
Although both FcyRI and FcyRIII rely on the FcRy chain for their surface expression and
signal transduction, the enhancement is normal in mice lacking FcyRIII, implying a
selective involvement of FcyRI in this process. Interestingly, FcyRIIB"'" mice show an
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over-enhancement of IgG-mediated enhancement (Wernersson et al, 1999), suggesting
that the inhibitory signaling via FcyRIIB counterbalances the activating effect of FcyRI
signaling in regulation of antibody responses to T-D antigens.

IgG-mediated suppression of T-I type II responses
Passive transfer of immune serum into naive recipients suppresses antibody responses
against T-I type II or haptenated particulate antigens administered in close temporal
proximity to serum transfer (Heyman, 2003). This suppressing activity of immune serum
is mediated by antigen-specific IgGj, IgG2a, IgG2b, and IgG3, but not other isotypes
(Briiggemann and Rajewsky, 1982) and is independent of complement engagement
(Heyman et al, 1988). The precise mechanism of IgG-mediated suppression of T-I type
II responses is unknown. Although isotype selectivity implies the involvement of an Fey
receptor, known Fey receptors do not appear to be involved in this process (Karlsson et
al, 1999; Karlsson etal, 2001).
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B Cell M e m o r y
Central to the phenomenon of acquired immunity is the concept of immunologic
memory—i.e., the ability of the immune system to generate an enhanced antibody
response against previously encountered antigens. In his work on staphylococcal toxoid,
Burnet reported that the primary antibody response was slow and of low titer, whereas
the secondary response rose rapidly to a higher titer (Burnet, 1940). In similar
experiments, secondary immunization of guinea pigs with a bacteriophage $X 174
resulted in accelerated production of anti-phage antibodies in the serum. Furthermore,
secondary serum showed 10-100 fold enhancement in phage-neutralizing capacity
compared with the serum obtained after primary immunization with the same dose of the
bacteriophage (Uhr et al, 1962).
It has been observed that serum affinity against T-D antigens increases
progressively with time after immunization in rabbits and guinea pigs (Eisen and Siskind,
1964; Siskind et al, 1968; Goidl et al, 1968). Such affinity maturation of antibody
responses appears to be due to somatic diversification of immunoglobulin V regions, first
uncovered by the analysis of the amino acid sequences of lgk chains from several murine
plasmacytoma-derived antibodies (Weigert etal, 1970).
Comparison of the nucleotide sequence of an lgk chain cloned from a mouse
embryo with that from an IgX,-secreting tumor cell line revealed that the latter carried
somatic mutations (Bernard et al, 1978). Further detailed analysis of antibody affinities
and nucleotide sequences of immunoglobulin V regions from hybridoma clones after
primary and secondary immunization with haptenated T-D antigens, such as
nitrophenylacetyl (Reth et al, 1978; Cumano and Rajewsky, 1985; Cumano and
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Rajewsky, 1986) or phenyloxazolone (Griffiths et al, 1984; Berek et al, 1985),

confirmed that somatic hypermutation is the molecular basis for affinity maturation of the
antibody response.
The clonal selection theory attributes immunologic memory to the formation of
quiescent "memory" cells derived from clonally expanded precursors during the primary
response and capable of giving rise to antibody-producing plasma cells upon secondary
activation. The existence of the quiescent cellular component of B cell memory was first
demonstrated by Okumura et al, who showed that FACS-purified IgG+ B cells from
primed mice develop into IgG-secreting plasma cells upon adoptive transfer and
immunization with the same antigen (Okumura et al, 1976). Since IgG+ B cells
constitute less than 1 % of all B cells, this experiment raised a question of how such a
small cellular compartment is able to contribute to robust IgG humoral responses. Martin
and Goodnow resolved this paradox by demonstrating that the membrane tail of IgG
enhances the extrafollicular proliferative burst of B cells (Martin and Goodnow, 2002).
T-D memory B cells are characterized by somatic mutations in their
immunoglobulin V regions (Siekevitz et al, 1987; Berek et al, 1987), by increased
affinity to antigen (Hayakawa et al, 1987), and by the lack of IgD expression in mice
(Black et al, 1978). BrdU studies have revealed that T-D memory B cells are long-lived
and are derived from proliferating precursors (Schittek and Rajewsky, 1990). Their longterm survival does not require T cells (Vieira and Rajewsky, 1990) or immunizing
antigen (Maruyama et al, 2000). Although memory B cells are typically B220+, a
distinct compartment of B220" memory B cells with somatically mutated V regions,
elicited by T-D antigens administered in Ribi adjuvant (a TLR4 ligand), has been
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described in mice (McHeyzer-Williams et al, 2000) and shown to accumulate both in the
spleen and in the bone marrow (Driver et al, 2001).
In humans, memory B cells are characterized by the expression of CD27
(Agematsu et al, 1997; Klein et al, 1998; Tangye et al, 1998; Agematsu et al, 2000).
Both IgM+ and IgM" memory B cells have been identified. Human IgM+ memory B cells
found in the blood correspond to splenic MZ B cells by surface marker phenotype and
gene expression profile (Weller et al, 2004). The development and/or maintenance of
this IgM+ memory B cell compartment is compromised in splenectomized or asplenic
patients, who are prone to infections by encapsulated bacteria and who do not respond to
T-independent polysaccharide vaccines (Kruetzmann et al, 2003).
T-independent B cell memory has been observed in the peritoneal B-lb cell
compartment in mice. B-lb cells from convalescing mice infected with B. hermsii
conferred better protection of RAG-1-deficient mice against the challenge with this
pathogen than Bib cells from naive mice. This enhanced protection did not require T
cells, somatic hypermutation, or isotype switching (Alugupalli et al, 2003).
It remains controversial whether T-I type II antigens elicit memory B cells. IgGmediated suppression precludes the analysis of secondary T-I type II responses.
Furthermore, very low level of somatic hypermutation during the T-I type II response
hinders the identification of T-I memory B cells by analyzing their immunoglobulin V
regions. To determine whether T-I type II responses generate memory B cells is the aim
of this thesis.
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Experimental Approach
A direct method of T-I memory B cell detection became possible with the
availability of knock-in mouse strains expressing BCRs of known specificities. In our
studies, we used previously generated knock-in mice expressing Bl-8 heavy chain
variants, Bl-8high and Bl-8low (Shih et al, 2002). The Bl-8 heavy chain (consisting of the
VH186.2, DFL16.1, and JH2 segments) in combination with the IgX,, light chain forms NPspecific BCR (Reth et al, 1978). The Bl-8hish allele was made by Tip to Leu
replacement at codon 33 in the CDR1 of the wild-type Bl-8 allele resulting in 10-fold
increase in BCR affinity to NP, whereas the Bl-8low allele contained four amino acid

substitutions that collectively decrease BCR affinity to NP by a factor of 4 relative to t
wild-type Bl-8 allele (Shih et al, 2002).
A large number of B cells of the same (anti-NP) specificity in Bl-8hlgh knock-in
mice allowed us to identify memory B cells generated during the immune response
against NP-Ficoll. We then confirmed the existence of T-I memory B cells in mice with
a normal (non-transgenic) B cell repertoire. Finally, we analyzed T-I memory B cells for
their phenotypic and functional properties and identified requirements for their
development and regulation of secondary activation.
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MATERIALS AND METHODS

Animals
C57BL/6 and TCR|3"'"&"'" mice were purchased from The Jackson Laboratories. AID"'

mice were provided by T. Honjo (Kyoto University, Kyoto, Japan), PKCp"'" mice by A

Tarakhovsky (Rockefeller University, New York, NY), FcyRIIB"'" and FcRy"'" mice by

Ravetch (Rockefeller University, New York, NY). Bl-8high and Bl-8low IgH knock-in
mice were generated previously and crossed to the CD45.1 -allotype C57BL/6
background. Blimp-l^0* CD19Crc/+ mice (Ohinata et al, 2005) and the Blimp-1YFP

reporter strain (provided by E. Meffre, Hospital for Special Surgery, New York, NY
were crossed to Bl-8high IgH (CD45.1) knock-in mice.
To create the Blimp-lCre strain, a bacterial artificial chromosome (BAC) clone
#452 P8 (Research Genetics) containing the prdm-1 gene encoding Blimp-1 was

modified using a PCR-based method (Misulovin et al, 2001). The coding region in th

first exon of prdm-1 was substituted by the first 100 bp of the Cre sequence prec
a nuclear localization sequence. The second exon of prdm-1 was replaced by the
remaining Cre sequence followed by a transcriptional STOP cassette. The modified

was linearized and microinjected into pronuclei of zygotes derived from B6CBAF1 m

Blimp-lCre mice were crossed to the ROSA26STOPEGFP reporter strain (Mao et al, 20
and to Bl-8high IgH (CD45.1) knock-in mice.
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F A C S analysis
To follow the time course of the T-I type II immune response, B l-8hlgh mice were

immunized i.p. with 50 u.g of NP190-Ficoll (Biosearchtech) and analyzed on day 0,

4 and 7 after immunization. The following antibodies were used for staining: Ki-6
FITC, CD86-FITC, I-Ab-FITC, Syndecan-1-PE, GL-7-FITC, Fas-PE, lgkbiotin/Streptavidin-PerCP, and B220-APC (BD Biosciences). All stainings were done
FACS buffer (PBS supplemented with 1% fetal bovine serum, FBS). Before Ki-67
staining, cells were fixed and permeabilized with Cytofix/Cytoperm buffer (BD

Biosciences) for 30 minutes, and Ki-67 staining was performed in Perm/Wash buffer

Biosciences). Similar stainings were done with Bl-8highBlimp-l"0^"* CD19Cre/+ mic
day 0, 2, and 4 after NP-Ficoll immunization.
For cell surface marker analysis of T-I and T-D memory B cells, CD45.T Bl-8high

B cells were adoptively transferred into wild-type mice, which were immunized i.p

50 p,g of NP190-Ficoll in PBS or with 50 ug of NP16-CGG (Biosearchtech) in Imject

(Pierce). FACS analysis was performed on day 15 after NP-Ficoll immunization or on

day 25 after NP-CGG immunization. The following antibodies were used for staining
CD21-FITC, CD23-PE, IgX,-biotin/Streptavidin-PerCP, and CD45.1-APC.
To analyze IgG/ and IgG3+ B cells from TCRp"'"8"'", PKCp'", wild-type, and AID"'"

mice, splenocytes were depleted with anti-CD43 and anti-IgM MACS beads (Miltenyi)
and stained with CD21-FITC, CD23-PE, Ig^-biotin/Streptavidin-PerCP, and B220-APC.
FACS acquisition was done on FACSCalibur (BD Biosciences). CELLQuest (BD
Biosciences) was used for FACS data analysis.
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F A C S sort

To test cells for antibody secretion, CD45.T Bl-8high B cells were adoptively tra

into wild-type mice, which were immunized i.p. with 50 \ig of NPI90-Ficoll. On day
after immunization, splenocytes were depleted with anti-CD43 MACS beads, stained
with B220-FITC, Syndecan-1-PE, IgX-biotin/Streptavidin-PeCy7, and CD45.1-APC. T-I
memory B cells were purified by FACS as B220+Syndecan-l"IgX+CD45.1+ cells. As a

negative control, B220+Syndecan-l"IgX,+ B cells were purified from naive Bl-8high

As a positive control, B220lowSyndecanl+ plasma cells were purified from Bl-8hlgh

on day 4 after i.p. immunization with 50 \xg of NP190-Ficoll. FACS sort was perfo
on FACSVantage SE (BD Biosciences). Sorted cells were analyzed by ELISPOT.

ELISPOT

For ELISPOT assay, plates were coated with 5 ug/ml of NP16-BSA (Biosearchtech) an
blocked for 2 hours with RPMI-R5 (RPMI Medium 1640 (Gibco) supplemented with 5%
heat-treated FBS, lOmM HEPES, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 U/ml

penicillin/streptomycin, and 55 uM |3-Mercaptoethanol). Sorted cells (naive B cell
memory B cells, and plasma cells) were plated (30,000 cells/well) and incubated
overnight in RPMI-R5. Cells were washed away with PBS, and plates were incubated
2 hours with HRP-conjugated anti-mouse Igk (Southern Biotechnology). ELISPOTs

were developed with AEC reagent (Vector) and analyzed by AID ELISPOT reader (Cell
Technology).
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Analysis of Blimp-1 expression using Blimp-1YFP reporter mice

To detect Blimp-1 expression during T-I type II response, Bl-8hlgh Blimp-1YFP mic

analyzed for YFP expression on day 0, 1, 2, 3, 4 and 15 after i.p. immunization w

pig of NP190-Ficoll. Cells were stained for Syndecan-1-PE, IgX,-biotin/Streptavid
PerCP, and B220-APC.
To detect cells derived from Blimp-1-expressing precursors, splenocytes from Bl8high Blimp-lCre Rosa26STOPEGFP (CD45.1) mice were depleted with anti-CD43 MACS

beads and sorted to exclude GFP+ cells. 20x106 sorted cells were adoptively trans

into wild-type (B6CBAF1) recipients, which were immunized i.p. with 50 \xg of NPI9
Ficoll or PBS and analyzed for GFP expression on day 5 and 15 after immunization.
Splenocytes were stained with Syndecan-1-PE, IgX,-biotin/Streptavidin-PerCP, and
CD45.1-APC.

Analysis of Blimp-1 expression by RT-PCR

Bl-8hlgh mice were immunized i.p. with 50 ug of NP190-Ficoll. On day 4, splenocyt
were depleted with anti-CD90.2 MACS beads (Miltenyi) and stained with B220-FITC

and Syndecan-1-PE to sort B220low Syndecan-1+ plasma cells. On day 15, splenocyte
were depleted with anti-CD43 MACS beads (Miltenyi) and stained with B220-FITC,

Syndecanl-PE, and IgX,-biotin/Streptavidin-PeCy5 to sort IgA7 B220+ Syndecan-1" B
cells.
Total RNA was obtained from sorted cells using TRIzol reagent (Invitrogen).

RNA was annealed with 0.1 fxg/ml of random hexamers by a 5-minute incubation at 7

followed by incubation at 4°C. cDNA was prepared by adding 200 units of Superscri
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II-RTase (Invitrogen) in the First Strand Buffer (Invitrogen) supplemented with 0.1M
DTT and 10 mM dNTPs, and incubating the mix at 42° C for 1 hour. The following
primers were used for PCR amplification of Blimp-1 and (3-actin:
Blimp-1 forward primer: GAAGAAACAGAATGGCAAGA;
Blimp-1 reverse primer: AGTTGCCCTTCAGGT;
P-actin forward primer: CCCTGAAGTACCCCATTGAAC;
P-actin reverse primer: GAAGTCTAGAGCAACATAGCACAGC.
PCR was done on serial (1:5) dilutions of cDNA with HotStarTaq (QIAGEN) at

50° C annealing for 33 cycles for Blimp-1 amplification and at 55° C annealing fo
cycles for |3-actin amplification.

NP coupling to 5. pneumoniae cells

S. pneumoniae cells (non-lytical Lyt4-4 variant of an acapsular strain R36A, prov
A. Tomasz, The Rockefeller University, New York, NY) were grown in C+Y medium

(Home et al, 1993) until they reached O.D. of 0.7 corresponding to a density of 1

per ml. Bacterial cells were pelleted by centrifugation and incubated for 5 minut
0.5 mg/ml NP-Succinimide ester, NP-OSu (Biosearchtech). The conjugation reaction
was quenched with 1.2 mg/ml glycylglycine (Sigma) in PBS, and the bacteria were
washed twice with PBS.
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B r d U pulse-chase
In BrdU pulse-chase experiments, splenic B cells from Bl-8hlgh or B1-8|0W mice were
purified by negative selection with anti-CD43 MACS beads. Approximately 2xl07
purified B cells per recipient mouse were injected i.v. When TCRp '"S"'~ mice were used

as recipients, an additional round of negative selection of Bl-8hlgh B cells was done with
anti-CD90 MACS beads. Mice were immunized i.p. with 50 u.g of NP190-Ficoll in PBS
or with 108 NP-coupled or noncoupled S. pneumoniae cells one day after adoptive
transfer, and fed 5-bromo-2'-deoxyuridine (BrdU, Sigma) in the drinking water at a
concentration of 0.5 mg/ml on days 1-5 after immunization. When indicated, secondary
NP-Ficoll immunization was performed in the absence of BrdU administration preceded
or not by second round of adoptive transfer of primed splenocytes into naive wild-type
recipients.

BrdU detection
For BrdU detection, cells that had been first stained with antibodies to cell surface
markers (GL7-FITC, Fas-PE, Syndecan-1-PE, B220-PerCP, IgG3-biotin, IgX,biotin/Streptavidin-PerCP, and CD45.1-APC) were treated with Cytofix/Cytoperm buffer
for 30 minutes, followed by a 10-minute incubation in 10% DMSO (in PBS) and a
second incubation in Cytofix/Cytoperm buffer. Cells were then incubated in FACS
buffer containing 5 mM MgCl2 and 20 units of DNAse I (Sigma) for 1 hour at 37° C, and
stained with FITC-conjugated anti-BrdU antibody (BD Biosciences) in Perm/Wash
buffer.
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C F S E labeling

B cells from naive Bl-8high (CD45.1) and NP-Ficoll primed Bl-8high (CD45.1/CD45.2

mice were purified by negative selection with anti-CD43 MACS beads. CFSE-labeling

was performed by incubating purified B cells (107 cells/ml) in PBS containing 5 u
CFDASE dye for 10 minutes at 37° C with subsequent PBS washes. B cells from both

groups were mixed together and adoptively transferred into naive C57BL/6 recipien
which were immunized i.p. with 0, 1,5, 10, and 50 ug of NPi90-Ficoll. CFSE dye

dilution was analyzed by FACS on day 5 after immunization in combination with Igk
CD45.2-biotin/Streptavidin-PerCP and CD45.1-APC staining.

ELISA
Mice were immunized i.p. with 50 ug of NP190-Ficoll, TNP^-Ficoll, or NP200-TNP44-

Ficoll (Biosearchtech). When indicated, primary immunization with lug of NP190-Fi
or secondary immunization (on day 42) with 50 ug of NP190-Ficoll was performed.
Before adoptive transfer of splenocytes from naive or NP-Ficoll primed wild-type
into PKCp'" recipients, splenocytes were stained with Syndecan-1-PE antibody and
depleted of Syndecan-1+ cells by anti-PE MACS beads (Miltenyi).
Mice were bled on day 0, 6, 15, 21, 42, 48, and 57. Serum was collected by

centrifuging coagulated blood for 15 minutes at 2,000 rpm. NP-specific antibody t

were measured by sandwich ELISA. High-binding plates (Costar) were coated overnig

with 5 ug/ml of NP2-BSA (Biosearchtech), blocked for 1 hour with PBS containing 0

Tween-20 and 1% BSA, incubated with serial (1:3) serum dilutions for 2 hours, fol
by a 2-hour incubation with HRP-conjugated anti-mouse IgM or IgG (Jackson
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ImmunoResearch Laboratories). ELISA plates were developed using 1-Step A B T S

reagent (Pierce) and read at the wavelength of 405 nm by VERS Amax microplate rea

(Molecular Devices). Titers were calculated using SOFTmax Pro (Molecular Devices)

and expressed in arbitrary units relative to an immune serum sample that was incl
all plates.

Anti-NP IgG antibody production
The 9T13 hybridoma cell line provided by T. Azuma (Tokyo University of Science,

Chiba, Japan) was the source of anti-NP IgG! antibody. 9T13 hybridoma was grown f
5-6 days in DMEM Medium (Gibco) supplemented with 10% heat-treated ultra-low IgG

FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, and 100 U/ml penicillin/streptomycin
Cells were spun down and supernatants were filtered and incubated overnight with

ml/L of protein G Sepharose beads (GE Healthcare). Beads were loaded on the colum

(1.5 ml of beads per column) and washed with PBS. Antibody was eluted with 4.5 ml
0.1M Glycine buffer (pH 3) and neutralized with 0.5 ml of 1M Tris buffer (pH 8).

Purified antibody was dialyzed overnight against PBS. Isotype control antibody (1
was purchased from the Rockefeller Monoclonal Antibody facility. 0.4 mg of each

antibody was injected i.v. one day before secondary NP-Ficoll immunization of AID
mice.
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RESULTS

PART I: PRIMARY T-INDEPENDENT TYPE II IMMUNE RESPONSE

Time-course of T-I type IIB cell response
The time course of the T-I type IIB cell response was analyzed in B l-8hlgh mice
immunized with NP-Ficoll. Splenic NP-specific IgX,+Bl-8hJgh B cells upregulated a
proliferation marker Ki-67 as early as day 1 after immunization. The peak of B cell
expansion and expression of activation markers CD86 and I-Ab was observed on day 2.
Syndecan-1+ plasma cells appeared on day 3, and GL-7+Fas+ T-I germinal centers—on
day 4 after immunization. By day 7, no proliferating or activated cells could be detected
(Figure 2).

T-I type II immune response generates memory B cells
We sought to determine whether NP-Ficoll immunization elicits memory B cells.
Assuming that quiescent memory B cells are derived from proliferating antigenexperienced precursors, we used an in vivo BrdU pulse-chase strategy for their detection.
To ensure that the analysis was not confounded by BrdU incorporation into dividing bone
marrow B cell precursors, we adoptively transferred allotype-marked (CD45.1) splenic B
cells from Bl-8hlgh IgH knock-in mice into naive wild-type recipients before
immunization and subsequently analyzed only the transferred population. Recipient mice
were immunized with NP-Ficoll and fed BrdU during the proliferative phase of the T-I
type II response (days 1-5), after which BrdU was withdrawn. Incorporation of BrdU
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into dividing B cells was assessed by F A C S analysis immediately after B r d U withdrawal.
To detect quiescent long-term survivors derived from proliferating precursors, BrdU
retention was assayed on day 15, 60, and 120 (Figure 3A). We detected allotype-marked
BrdU-labeled B cells in the spleen of NP-Ficoll immunized recipients, but not in control
recipients injected with PBS and fed BrdU (Figure 3B). BrdU-labeled B cells were Ig?i+
(Figure 3B) and thus NP-specific (Reth et al, 1978; Shih et al, 2002). Because
subsequent cell division in the absence of BrdU (days 5-120) would have resulted in loss
of BrdU by dilution, the detected BrdU-labeled cells must be quiescent.
The above BrdU pulse-chase strategy might have labeled long-lived terminally
differentiated plasma cells and/or quiescent memory B cells. To distinguish between
these cell types, we analyzed BrdU-labeled cells for the expression of a plasma cell
marker (Syndecan-1) and for antibody secretion. The majority of BrdU-labeled cells
expressed a B cell marker (B220), although at lower levels than naive B cells, and were
Syndecan-1" (Figure 3C). To make sure that BrdU-labeled cells did not secrete
antibodies, we purified IgX+ Bl-8hlgh B cells by FACS on day 15 after adoptive transfer
and NP-Ficoll immunization and tested them for antibody secretion by ELISPOT. They
did not secrete antibodies (Figure 3D). Consistent with the possibility that BrdU-labeled
cells were memory B cells, 8% expressed a secondary Ig isotype (IgG3) on their surface
(Figure 3C). We conclude that quiescent BrdU-labeled B220low Syndecan-1" lgk+ B l-8high
B cells formed during the immune response to NP-Ficoll are memory B cells.
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NP-Ficoll elicits m e m o r y B cells in the absence of T cells
Immune responses against polysaccharides do not require T cells for antibody production
(Mond et al, 1995). To test T cell requirement for the development of memory B cells
against polysaccharides, we repeated BrdU pulse-chase in T cell-deficient mice.
Allotype-marked (CD45.1) Bl-8high B cells were adoptively transferred into TCRP"'^"'recipients, which were immunized with NP-Ficoll or PBS and fed BrdU. To ensure that
the transferred B cell sample was not contaminated with T cells, we performed double
depletion of T cells by CD90-MACS beads and confirmed the purity of the sample by
CD3 staining (not shown). BrdU-labeled IgX+Bl-8hlgh memory B cells were detected in
TCRP"'"8"'" recipients on day 15 after NP-Ficoll immunization (Figure 4). Thus, T cells
are not required for the development of memory B cells elicited by NP-Ficoll.

NP-specific memory B cells are elicited by NP-coupled 5. pneumoniae
Pathogens that induce T-I type II responses include bacteria such as S. pneumoniae. We

tested whether, similar to NP-Ficoll, antigens carried on the bacterial cell surface elici
memory B cells. Allotype-marked (CD45.1) Bl-8h,gh B cells were adoptively transferred
into wild-type recipients, which were immunized with NP-coupled or non-coupled S.
pneumoniae and fed BrdU. The immune response against NP-S. pneumoniae, but not
against non-coupled bacteria, generated NP-specific (IgX,+) memory B cells detected by
BrdU staining on day 15 after immunization (Figure 5). Therefore, pathogens that induce
T-I type II immune responses stimulate production of memory B cells.
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T-I m e m o r y B cells resemble naive B cells in their lifespan and sensitivity to
polysaccharide antigens
To estimate the lifespan of T-I memory B cells, we compared their survival to that of
naive B cells. Adoptively transferred naive lgk+B l-8high B cells initially constituted
0.27% of total splenocytes, and in the absence of immunization their number declined
gradually, reaching half of the initial input in approximately 90 days (Figure 6). NPFicoll immunization resulted in 10-fold expansion of this population by day 5, followed
by a sharp decline from 2.7% to 0.7% of total splenocytes between day 5 and 30 (Figure

6). This loss of IgX,+ Bl-8hlgh B cells in immunized recipients was disproportionate to th

loss of IgX.+ Bl-8hlgh B cells in naive recipients during the same time period (from 0.27%
to 0.22%). After day 30, however, the half-life of the IgX+Bl-8high B cell population was
equivalent in immunized and naive recipients. Notably, IgX+Bl-8hlgh B cells remained
more numerous in immunized than in naive recipients for up to 4 months. These results
suggest that after the initial expansion and loss of B cells responding to T-I type II
antigens, an expanded long-lived population of memory B cells is maintained with a halflife similar to that of naive B cells (approximately 90 days).
We next compared the sensitivity of naive and T-I memory B cells to various
doses of NP-Ficoll. B cells from naive or NP-Ficoll primed Bl-8hlgh IgH knock-in mice
expressing CD45.1 or CD45.1/CD45.2 allotypes, respectively, were purified, labeled
with CFSE, and adoptively transferred into wild-type recipients. NP-Ficoll priming was
done 30 days before the adoptive transfer. The proliferative response of transferred Bl8high B cells was assessed by CFSE dilution on day 5 after NP-Ficoll immunization of
recipients (Figure 7A). We found no difference between naive and primed IgX+ Bl-8high
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B cells in their responsiveness to doses of NP-Ficoll ranging from 1 to 50 \ig (Figure 7B).
This suggests that naive and T-I memory B cells of the same antigen affinity have similar
sensitivity to polysaccharide antigens.

T-I and T-D memory B cells have distinct cell surface marker phenotypes
To determine whether there are phenotypic differences between T-I and T-D memory B
cells, we examined their cell surface marker phenotype. B l-8hlgh B cells were adoptively
transferred into wild-type recipients, which were immunized either with NP-Ficoll or
with a T-D antigen NP-chicken y globulin (NP-CGG) (Figure 8A). IgX+Bl-8high memory
B cells that developed during T-I or T-D responses differed in the pattern of CD21 versus
CD23 expression: the former expressed low levels of CD21 and CD23, whereas the latter
resembled follicular (CD21lowCD23high) and MZ (CD21highCD23,0W) B cells (Figure 8B).
To determine whether such phenotypic differences are found in naturally
generated memory B cell populations of T-I or T-D origin, we analyzed the phenotype of
memory B cells identified by surface expression of IgG1+IgG3 in aged TCRP"'""5"'",
PKCP"'", and wild-type mice (Figure 9). IgG+ memory B cells in TCRp~'~8 ~~ mice,
which can generate only T-I responses, showed the pattern of CD21 versus CD23
expression similar to that of IgX,+ Bl-8hlgh memory B cells derived from NP-Ficoll
immunization. In contrast, PKCP"'" mice, which can generate only T-D responses
(Leitges et al, 1996), accumulated IgG+ memory B cells resembling IgX,+ Bl-8high
memory B cells derived from NP-CGG immunization. Finally, in wild-type mice IgG+ B
cells with the T-I memory phenotype (CD21lowCD23low) constituted about 50% of the
total IgG+ B cell pool. These results indicate that naturally arising T-I memory B cells
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show the same surface phenotype as IgX+Bl-8high m e m o r y B cells that develop in
response to NP-Ficoll immunization. Furthermore, T-I memory B cells are
phenotypically distinct from conventional T-D memory B cells and constitute a
significant portion of the total IgG+ memory B cell pool.

BCR affinity regulates development of T-I memory B cells
To determine the effect of BCR affinity on the development of T-I memory B cells, we
performed BrdU pulse-chase using Bl-8low B cells, whose BCR affinity to NP is 4-fold
lower than that of B cells expressing the wild-type Bl-8 IgH allele. Allotype-marked
(CD45.1) Bl-8low B cells were adoptively transferred into wild-type recipients, which
were immunized with NP-Ficoll or PBS and fed BrdU. BrdU incorporation into Bl-8low
B cells was assayed on day 5 after NP-Ficoll immunization, and BrdU retention by Bl8lovv memory B cells-on day 15 (Figure 10A). Bl-8low B cells responded to NP-Ficoll
immunization but failed to develop the memory compartment (Figures 10B and IOC).
Bl-8low B cells might have been unable to develop the memory compartment
either due to the intrinsically low affinity of their antigen receptor or due to the
competition with B cells of higher affinity to NP present in wild-type recipients. To

distinguish between these possibilities, we next used PKCp'" mice as recipients of Bl-8low
B cells. Because of the B cell-autonomous defect in T-I type II antibody responses in
PKCp'" mice (Leitges et al, 1996), the development of the Bl-8low memory B cell
compartment in response to NP-Ficoll immunization would occur in the absence of
potential competition with endogenous B cells. BrdU-labeled Bl-8low memory B cells
were detected in PKCp'" recipients on day 15 after NP-Ficoll immunization (Figure 10B).
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W e conclude that affinity-based competition, rather than intrinsic antigen affinity of the
BCR, regulates the development of the T-I memory B cell compartment.

Blimp-1 expression is restricted to plasma cells during T-I type II immune response
Attempting to identify factors involved in T-I memory B cell development, we tested the
formation of T-I memory B cells by means of BrdU pulse-chase in a number of knockout strains crossed to B l-8hlgh IgH knock-in mice. We found that B cell deficiency in a
transcription factor Blimp-1 affected the formation or detection of BrdU-labeled memory
B cells in response to NP-Ficoll immunization (data not shown). We therefore examined
the role of Blimp-1 in the T-I type IIB cell response.
First, we analyzed Blimp-1 expression during the course of the T-I type II
response in Blimp-1YFP reporter mice crossed to the B l-8hlgh IgH knock-in strain. Mice
were immunized with NP-Ficoll, and YFP expression, representing Blimp-1 expression,
was analyzed by FACS on day 0, 1, 2, 3, 4, and 15 after immunization. YFP+Syndecan1+cells were detected on day 3 and 4 after immunization. No other YFP+ population
could be detected throughout the course of the T-I type II B cell response (Figure 11 A).
Blimp-1 expression by purified Syndecan-1+ plasma cells on day 4, but not by NPspecific B cells on day 15, was confirmed by RT-PCR (Figure 1 IB).

BIimp-1-deficient B cells respond to NP-Ficoll immunization but fail to give rise
to plasma cells
To examine the effect of Blimp-1 deficiency on T-I type II responses, Bl-8highor Bl-8high
Blimp-lflox/flox CD 19Cre/+ mice were immunized with NP-Ficoll and their splenocytes were
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analyzed on day 0, 2, and 4 after immunization for proliferation, expression of activation

markers, and the formation of plasma cells and germinal centers. Bl-8hlgh Blimp-lflox/flox
CD19Cre'+ mice showed normal proliferation and activation of NP-specific (IgX+) B cells
on day 2 after NP-Ficoll immunization, but had a significantly reduced number of
Syndecan-1+ plasma cells and an increased number of GC B cells on day 4 (Figure 12).
Thus, Blimp-1 deficiency compromises plasma cell development, but does not appear to
affect B cell activation in response to NP-Ficoll immunization.

T-I memory B cells are not derived from Blimp-1-expressing precursors
Next, we performed genetic tracing using the Cre-lox recombination strategy to test
whether T-I memory B cells are derived from Blimp-1 expressing precursors. Crerecombinase was introduced into a BAC containing the prdm-1 gene encoding Blimp-1.
Blimp- lCre BAC-transgenic mice were bred with the Rosa26STOPEGFP reporter strain with a
floxed transcriptional STOP cassette (Mao et al, 2001). In this system, Cre-recombinase
expression leads to the excision of the STOP cassette in Blimp-1-expressing cells.
Subsequent expression of GFP in all progeny cells is independent of further Blimp-1
expression (Figure 13).
A fraction of B cells in Blimp-lCreRosa26STOPEGFP mice were GFP positive in the
absence of any immunization (not shown). GFP" B cells were purified by FACS from
Bl-8highBlimp-lCreRosa26STOPEGFP mice expressing CD45.1 allotype and adoptively
transferred into wild-type recipients, which were immunized with NP-Ficoll or PBS.
GFP expression was analyzed on day 5 and 15 after immunization (Figure 14A). At both
time points, immunization-specific GFP expression was restricted to Syndecan-1+ plasma
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cells (Figure 14B). The majority of IgX+ Bl-8high m e m o r y B cells, detected on day 15
after NP-Ficoll immunization, did not express GFP and thus were not derived from
Blimp-1-expressing precursors.
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Figure 2. I m m u n e response to NP-Ficoll.

Ki-67, CD86,1-A\ B220 versus Syndecan-1, and Fas versus GL-7 staining of
splenocytes from NP-Ficoll immunized Bl-8high mice analyzed at the indicated

time points. Broken lines in histogram overlays represent levels of Ki-67, CD8
and I-Ab expression in naive mice. Gated on lgk+ (NP-specific) B cells.
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Figure 3. NP-Ficoll immunization elicits m e m o r y B cells.

(A). BrdU pulse-chase strategy. Allotype-marked (CD45.1) Bl-8high B cells were
adoptively transferred into wild-type recipients, which were immunized with NPFicoll or PBS and fed BrdU in drinking water (days 1-5). Incorporation/retention
of BrdU was assayed on day 5, 15, 60, and 120.

(B). BrdU staining of adoptively transferred Bl-8high B cells (top) and IgX, staining
of BrdU-gated Bl-8high B cells (bottom) from NP-Ficoll immunized or naive wildtype recipients analyzed at the indicated time points. Gated on CD45.1+ cells.

(C). B220 versus Syndecan-1 and B220 versus IgG3 staining of Bl-8high B cells
from naive recipients on day 15 after adoptive transfer (left) and of BrdU-gated
Bl-8hlgh B cells from NP-Ficoll immunized recipients on day 15 after adoptive
transfer and immunization (right). Gated on CD45.1+ cells.

(D). ELISPOT assay for antibody secretion by purified naive B cells, memory B
cells, and plasma cells. Naive B cells (IgX+B220+Syndecan-1") were purified by
FACS from Bl-8high mice; memory B cells (IgX+B220low Syndecan-1"CD45.U)
were purified from wild-type mice, 15 days after they received allotype-marked
(CD45.1) Bl-8high B cells and were immunized with NP-Ficoll; plasma cells (lgk+
B220lowSyndecan-l+) were purified from Bl-8hlgh mice on day 4 after NP-Ficoll
immunization.
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Figure 4. NP-Ficoll can elicit m e m o r y B cells in the absence of T cells.

BrdU pulse-chase was performed as indicated in Figure 2A, except that
TCRP"'"6_/" mice were used as recipients, and the experiment was carried out until
day 15. Histograms represent BrdU staining of adoptively transferred Bl-8h,gh B
cells (top) and IgX staining of BrdU-gated Bl-8high B cells (bottom) from NPFicoll immunized or naive TCRP"/-6"/- recipients analyzed at the indicated time
points. Gated on CD45.T cells.

44

B1-8hi9h B cells — > TCRp'8'mice

day 5

day 15

day 15 (PBS)

Figure 5. NP-conjugated 5. pneumoniae elicit NP-specific m e m o r y B cells.

BrdU pulse-chase was performed as indicated in Figure 2A, except that recipient
mice were injected with NP-conjugated or unconjugated S. pneumoniae cells, and
the experiment was carried out until day 15. Histograms represent BrdU staining
of adoptively transferred Bl-8hlgh B cells (top) and IgX, staining of BrdU-gated Bl8hlgh B cells (bottom) from wild-type recipients immunized with NP-coupled (NPStrep) or non-coupled (Strep) S. pneumoniae and analyzed at the indicated time
points. Gated on CD45.U cells.
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Figure 6. Survival of adoptively transferred IgX+Bl-8bW' B cells in NP-Ficoll
immunized and naive wild-type recipients.

Wild-type mice were adoptively transferred with allotype-marked (CD45.1) Bl8high B cells and immunized with NP-Ficoll or PBS. The number of IgX+Bl-8high
B cells per total splenocytes is plotted against the time after adoptive transfer.
Average values for each time point are plotted as bars.
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Figure 7. Similar sensitivity of primed and naive IgX+Bl-8high B cells to N P Ficoll.

(A). Experimental strategy. CD45.1 or CD45.1/CD45.2 Bl-8high mice were
primed with PBS or NP-Ficoll, respectively. On day 30 after priming, B cells

from both groups were purified, labeled with CFSE, and co-transferred into nai
wild-type (CD45.2) recipients, which were immunized with a range of NP-Ficoll
doses.

(B). CFSE dilution by adoptively transferred naive or NP-Ficoll primed IgX,+ B

8hlgh B cells on day 5 after NP-Ficoll immunization. Doses of NP-Ficoll used f
immunization are indicated. Gated on CD45.T (naive) or CD45.1+CD45.2+
(primed) IgX+ (NP-specific) B cells.
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Figure 8. Distinct phenotypes of m e m o r y B cells elicited by NP-Ficoll versus
NP-CGG.
(A). Experimental strategy. Allotype-marked (CD45.1) Bl-8high B cells were

adoptively transferred into wild-type recipients, which were immunized with NP
Ficoll or NP-CGG. FACS analysis was done on day 15 after NP-Ficoll
immunization and on day 25 after NP-CGG immunization.

(B). CD21 versus CD23 staining of adoptively transferred IgX+Bl-8high B cells
from mice immunized with NP-Ficoll or NP-CGG. Gated on CD45.1+IgV (NPspecific) B cells.
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Figure 9. Phenotype of IgG+ m e m o r y B cells in mice with normal B cell
repertoire.

B220 versus IgG!+IgG3 staining of splenocytes from TCRp'S"', PKCP"', wildtype, and AID"'" mice (top) and CD21 versus CD23 staining of IgG1+IgG3-gated B
cells (bottom). Splenocytes from AID"'" mice deficient in class switch
recombination are included as a negative control for anti-IgG staining.
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Figure 10. B C R affinity regulates development of T-I m e m o r y B cells.

(A). BrdU pulse-chase strategy. Allotype-marked (CD45.1) Bl-8low B cells were
adoptively transferred into wild-type or PKCP"'" recipients, which were
immunized with NP-Ficoll or PBS and fed BrdU in drinking water (days 1-5).
Incorporation/retention of BrdU was assayed on day 5 and 15.

(B). BrdU staining of adoptively transferred Bl-8low B cells from wild-type or
PKCp'" recipients immunized with NP-Ficoll or PBS and analyzed at the
indicated time points. Percentages of BrdU+ cells are indicated. Gated on
CD45.U cells.

(C). B220 versus Syndecan-1 (left) and Fas versus GL-7 (right) staining of
adoptively transferred BrdU-labeled Bl-8low B cells on day 5 after NP-Ficoll
immunization of wild-type or PKCp'" recipients. Gated on CD45.U cells.

56

adoptive transfer of
splenic B1-8"""B cells

analysis

analysis

BrdU ini I
drinking water '
days

-1

0

1

15

t
NP-Ficoll or P B S

B.
day 5

WT

J7

36%

day 15

day 15 (PBS)

day 5

4%

recipients
10° 101 102 103 10 10° 101 I02 103 10 10° 101 102 103 io*1
PKCP'- K
recipients
I
10u
iu

5 0 %
I (111 | I I III!
10' m10^"1 1m0*J* 10 10" 10" 102 103 10 10° 101 ID2 103 to*1
in1
BrdU

10° 101 102 io3 w4
Syndecan-1

"w" to' 102 103 104
GL-7

Figure 11. Blimp-1 expression during T-I type II immune response.

(A). FACS analysis of Blimp-1 expression. Syndecan-1 versus Blimp-1-YFP
staining of splenocytes from NP-Ficoll immunized Bl-8hlgh Blimp-1YFP mice
analyzed at the indicated time points. Gated on IgX+ (NP-specific) B cells.

(B). RT-PCR analysis of Blimp-1 expression. Plasma cells were sorted as B220lo
Syndecan-1+ cells from splenocytes of Bl-8hlgh mice on day 4 after NP-Ficoll
immunization. NP-specific B cells were sorted as lgk+B220+ Syndecan-1" cells
from splenocytes of Bl-8hlgh mice on day 15 after NP-Ficoll immunization.
Blimp-1 and P-actin expression was detected by RT-PCR.
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Figure 12. Blimp-1-deficient B cells respond to NP-Ficoll immunization but
do not give rise to plasma cells.

Ki-67, CD86,1-Ab, B220 versus Syndecan-1, and Fas versus GL-7 staining of
splenocytes from NP-Ficoll immunized Bl-8high or Bl-8high Blimp-lflox/flox
CD19Cre/+ mice at the indicated time points. Broken lines in histogram overlays
represent levels of Ki-67, CD86 and I-Ab expression in naive mice. Percentages
of plasma cells and GC cells are indicated. Gated on lgk+ (NP-specific) B cells.
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Figure 13. Strategy for genetic tracing of cells derived from Blimp-1expressing precursors.

Blimp-lCre BAC-transgenic mice were crossed to the Rosa26STOPEGFP reporter
strain with a floxed transcriptional STOP cassette. Blimp-1 upregulation results
in Cre-recombinase expression, allowing excision of the STOP cassette and
leading to constitutive GFP expression under the Rosa26 promoter independent of
further expression of Blimp-1.
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Figure 14. T-I m e m o r y B cells are not derived from BHmp-1-expressing
precursors.
(A). Experimental strategy. Allotype-marked (CD45.1) GFP" B cells from Bl8highBlimp-lCreRosa26STOPEGFP mice were purified by FACS and adoptively

transferred into wild-type recipients, which were immunized with NP-Ficoll or
PBS. GFP expression was analyzed on day 5 and 15.

(B). Syndecan-1 versus Rosa26-G¥P and IgX versus Rosa26-G¥P staining of

adoptively transferred B cells analyzed at the indicated time points. Gated o
CD45.1+cells.
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P A R T II: S E C O N D A R Y T - I N D E P E N D E N T T Y P E II I M M U N E R E S P O N S E

Absence of T-I type II recall response in mice primed with high antigen dose
Primary immunization with NP-Ficoll results in a rapid and long-lasting antibody
production (Vinuesa et al, 1999). We immunized wild-type mice with 50 or 1 u.g of

Ficoll, followed by a 50 u.g dose 6 weeks later. Mice primed with the low dose of

Ficoll responded to secondary immunization with the high dose. However, mice prim

with the high dose generated no further increase in anti-NP IgM and IgG titers af

secondary immunization compared with those established after primary immunization
(Figures 15A and 15B).
Immune serum plays a role in the suppression of T-I type II recall responses
(Hosokawa, 1979; Brodeur and Wortis, 1980). We purified splenocytes from naive or

NP-Ficoll primed wild-type mice two weeks after priming, depleted them of Syndeca

plasma cells, and adoptively transferred into naive PKCp'" recipients, which have

cell-autonomous defect in T-I type II responses (Leitges et al, 1996). Recipient m

were immunized with NP-Ficoll or PBS. The recipients of primed splenocytes produc
IgM and IgG antibody responses against NP-Ficoll, as did the recipients of naive

splenocytes, whereas control PKCP"'" mice receiving no cell transfer failed to re

(Figures 16A and 16B). These results confirm that B cells are unresponsive to sec
immunization with NP-Ficoll in primed mice, but their responsiveness is restored
adoptive transfer into naive mice.
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Antigen-specific I g G antibodies regulate activation of T-I m e m o r y B cells
We next tested whether T-I memory B cells respond to polysaccharide antigens. To
generate and label T-I memory B cells, allotype-marked (CD45.1) Bl-8high B cells were
adoptively transferred into wild-type mice, which were immunized with NP-Ficoll and
fed BrdU (days 1-5). On day 20, splenocytes were adoptively transferred into a second
group of naive wild-type recipients, which were injected with PBS or immunized with
NP-Ficoll (Figure 17A). Alternatively, NP-Ficoll primed mice were injected with PBS or
re-immunized with NP-Ficoll on day 20 after primary immunization (Figure 17C). By
day 5 after secondary immunization with NP-Ficoll, but not with PBS, BrdU-labeled
memory B cells that had been adoptively transferred into naive recipients lost BrdU due
to their proliferation leading to BrdU dilution (Figure 17B). In contrast, BrdU-labeled
memory B cells that had not been adoptively transferred into naive recipients retained
BrdU (Figure 17D), thus not responding to secondary immunization with NP-Ficoll.
Remarkably, this inhibition of memory B cell activation in response to secondary NPFicoll immunization was not observed in AID"'" mice (Figure 17D), deficient in class
switch recombination (Muramatsu et al, 2000). These results indicate that T-I memory
B cells are responsive to secondary immunization with polysaccharide antigens; however,
their activation is suppressed in primed wild-type mice but not in AID-deficient or naive
mice.
T o determine whether antigen-specific IgG antibodies account for the suppression

of the T-I type II recall response, we first tested the recall response to NP-Ficoll in AI
mice, which lack IgG (Muramatsu et al, 2000). Secondary immunization boosted NPspecific IgM titers in AID-deficient but not in wild-type mice (Figure 18A). Next, we
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injected AID"'" mice with NP-specific IgG, non-specific IgG, or P B S one day before
secondary NP-Ficoll immunization. Only NP-specific antibody suppressed the recall
response to NP-Ficoll in AID"'" mice (Figure 18B). We conclude that antigen-specific
IgG antibodies are necessary and sufficient for the suppression of T-I type II recall
responses.

IgG-mediated suppression of T-I type II immune response does not depend on
epitope masking
To test whether epitope masking accounts for the suppression of T-I type II immune
responses by antigen-specific antibodies, wild-type mice were primed with TNP-Ficoll or
PBS and two weeks later immunized with NP-Ficoll or doubly-conjugated NP/TNPFicoll. As expected, TNP-Ficoll priming did not affect the antibody response against NPFicoll. In contrast, TNP-Ficoll priming caused a 6-fold reduction in anti-NP antibody
titers in response to NP/TNP-Ficoll immunization relative to the PBS priming control
(Figures 19A and 19B). These results indicate that subsequent T-I type II immune
responses against non-crossreacting epitopes carried on the same molecule are suppressed
in animals immune just to one of the epitopes. Thus, epitope masking is not a mechanism
of IgG-mediated suppression.

IgG-mediated suppression of T-I type II recall response does not involve known
Fey receptors
To determine whether IgG-mediated suppression of T-I type II recall responses requires
any of the known Fey receptors, we tested the recall response to NP-Ficoll in FcyRIIB"'"
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and FcRy"'" mice. Secondary NP-Ficoll immunization did not boost NP-specific antibody
titers in these mice (Figures 20A and 20B). Thus, neither FcyRIIB nor any of the FcRy
chain-associated receptors are involved in IgG-mediated suppression of T-I type II recall
responses.
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Figure 15. Lack of recall response in mice primed with high dose of N P Ficoll.

Wild-type mice were immunized with 50 or 1 p,g of NP-Ficoll and reimmunized

with 50 \ig of NP-Ficoll six weeks later. NP-specific IgM (A) and IgG (B) tite
were measured by ELISA and plotted against the time after primary and
secondary immunization. Average values are plotted as bars.
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Figure 16. Recall response to NP-Ficoll is restored upon adoptive transfer of
splenocytes from primed mice into naive recipients.

Wild-type mice were primed with NP-Ficoll or PBS. On day 15, splenocytes
from naive and primed donors were isolated, depleted of Syndecan-1+ plasma
cells, and adoptively transferred into naive PKCp'" recipients, which were
immunized with NP-Ficoll or PBS. PKCp'" mice receiving no cell transfer were
immunized as a negative control. NP-specific IgM (A) and IgG (B) titers were
measured by ELISA on day 6 and 12, respectively.

72

W T donors - > PKCp-'- recipients

A.

anti-NP IgM (day 6)

OJ 100 ;
4-.
'c
CD 8°>
CD 60 J

immunization: NP-Fic P B S
transferred cells: NP-Fic primed

B.

NP-Fic P B S
naive

NP-Fic
no transfer

anti-NP IgG (day 12)

CD
>

CD
CD loo -

immunization: NP-Fic P B S
transferred cells: NP-Fic primed

NP-Fic P B S
naive

NP-Fic
no transfer

Figure 17. Suppression of T-I m e m o r y B cell activation.

(A and B). Allotype-marked (CD45.1) Bl-8high B cells were adoptively transferr
into wild-type recipients, which were immunized with NP-Ficoll and fed BrdU

(days 1-5). On day 20, primed splenocytes were adoptively transferred into a n
group of naive recipients, which were injected with PBS or immunized with NPFicoll. FACS analysis of BrdU loss/retention was done on day 5 after
immunization. Gated on CD45.1+ cells.

(C and D). Allotype-marked (CD45.1) Bl-8high or AID"'"Bl-8high B cells were

adoptively transferred into wild-type or AID"'" recipients, respectively, which
immunized with NP-Ficoll and fed BrdU (days 1-5). On day 20, recipients were
injected with PBS or re-immunized with NP-Ficoll. FACS analysis of BrdU
loss/retention was done on day 5 after secondary immunization. Gated on
CD45.T cells.
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Figure 18. Antigen-specific IgG antibodies account for suppression of recall
response to NP-Ficoll.

(A). AID"'" and wild-type mice were immunized with NP-Ficoll and reimmunized
six weeks later. NP-specific IgM titers were measured by ELISA and plotted
against the time after primary and secondary immunization. Average values are
plotted as bars.

(B). NP-specific IgM titers on day 5 after secondary NP-Ficoll immunization of
AID"'" mice, pre-injected with NP-specific IgG, non-specific IgG, or PBS. All
mice were primed with NP-Ficoll one month before secondary immunization.
Background IgM titer values (before secondary immunization) were subtracted.
Average values are plotted as bars.
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Figure 19. Epitope masking is not a mechanism of IgG-mediated
suppression.

Wild-type mice were primed with TNP-Ficoll or PBS two weeks before
immunization with NP-Ficoll or doubly-conjugated NP/TNP-Ficoll. NP-specific
IgM (A) and IgG (B) titers were measured by ELISA on day 6 and 13,
respectively.
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Figure 20. IgG-mediated suppression of recall response to NP-Ficoll does not
involve FcyRIIB or FcRy chain.

(A). FcyRIIB"'" and wild-type mice were immunized with NP-Ficoll and
reimmunized six weeks later. NP-specific IgM titers were measured by ELISA

and plotted against the time after primary and secondary immunization. Average
values are plotted as bars.

(B). FcRy"'" and wild-type mice were immunized with NP-Ficoll and reimmunized
six weeks later. NP-specific IgM titers were measured by ELISA and plotted
against the time after primary and secondary immunization. Average values are
plotted as bars.
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DISCUSSION

Characteristics of memory B cells elicited by T-I type II antigens
It has long been debated whether T-I type II responses generate memory B cells. The
criterion for B cell memory has been the detection of antigen recall response. Although
T-I type II antigens do not elicit recall responses (Hosokawa, 1979; Brodeur and Wortis,
1980; Schuler et al, 1984; Zhang et al, 1988), it has become apparent that this is due to
the suppression of T-I type II immune responses by factor(s) present in the immune
serum. Primed splenocytes could respond to secondary immunization when adoptively
transferred into naive irradiated wild-type recipients, and injection of the immune serum
before the adoptive transfer suppressed this response (Hosokawa, 1979; Brodeur and
Wortis, 1980). These findings were consistent with the possibility that T-I type II
responses generate memory B cells, although it was unclear whether the transferred cells
responding to second immunization in naive recipients were indeed memory B cells.
We have uncovered memory B cells elicited by polysaccharides and bacteria.
Assuming that memory B cells are derived from proliferating antigen-experienced

precursors, we used the BrdU pulse-chase strategy for their detection in the Bl-8hlgh B ce
adoptive transfer system. We show that the majority of BrdU-labeled B l-8h,gh B cells
detected in the spleen of the recipient mice after NP-Ficoll immunization have the

characteristics of memory B cells. They are quiescent, long-lived cells that do not secrete
antibodies and express a B cell marker B220, but not a plasma cell marker Syndecan-1.
Furthermore, T cells are not required for the development of Bl-8high memory B cells
elicited by NP-Ficoll.
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Unlike m e m o r y B cells that develop after N P - C G G immunization, the majority of
T-I memory B cells against NP-Ficoll express low levels of CD21 and CD23. This
phenotype distinguishes them from follicular and MZ B cells but not from immature B
cells. However, unlike immature B cells, T-I memory B cells are long-lived and contain
a small portion of IgG3+ cells. Phenotypic resemblance between T-I memory B cells and
immature B cells necessitates identification of a T-I memory B cell specific marker to
facilitate their analysis in the absence of BrdU pulse-chase.
Our initial identification of T-I memory B cells was done in the Bl-8hlgh adoptive
transfer system, which relies on high affinity and higher than normal frequencies of
antigen-specific B cells (0.2-0.3% of total splenocytes). We therefore needed to confirm

that T-I memory B cells exist in mice with a normal (non-transgenic) B cell repertoire. In
the absence of a specific T-I memory B cell marker, we identified memory B cells in
unmanipulated mice by surface IgG expression and low expression of CD21 and CD23.
We found that T cell-deficient mice, capable only of T-I immune responses, contained
B220+IgG+ B cells with the CD21lowCD23low phenotype similar to that of Bl-8high T-I
memory B cells elicited by NP-Ficoll immunization. In wild type mice, this
compartment constituted about one-half of IgG+ memory B cells. Although this analysis
is by necessity restricted to the IgG+ memory B cells (which constitute about 10% of T-I
memory B cells), it validates our findings in the Bl-8h,gh adoptive transfer system.
The main route for T-D memory B cell development is the GC reaction (Kocks
and Rajewsky, 1989; Rajewsky, 1996; McHeyzer-Williams and McHeyzer-Williams,
2005). However, somatically unmutated memory B cells are elicited by T-D antigens in
Bcl-6"'" mice, in which the GC reaction is compromised (Toyama et al, 2002) and in
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wild-type mice treated with anti-ICOS antibodies that inhibit the G C reaction (Inamine et
al, 2005). These memory B cells might be derived from the extrafollicular response to
T-D antigens. It remains to be determined whether T-I memory B cells, identified here,
originate from the T-I GC reaction or from the extrafollicular response to T-I type II
antigens.

T-I memory B cell longevity and responsiveness to antigens
We have determined that BrdU-labeled T-I memory B cells elicited by NP-Ficoll could
be detected up to 4 months after immunization. We wished to compare their lifespan
with that of naive B cells.
The lifespan of naive B cells had been previously estimated using BrdU labeling.

The half-life of the splenic B cell compartment, the time point at which 50% of all B cells
are labeled with BrdU upon continuous administration, appeared to be 6 weeks in adult
mice and 2 weeks in young mice (Forster et al, 1990). This is an underestimate for the
half-life of mature naive B cells, because splenic B cells also contain short-lived
immature B cells, whose half-life is about 4 days (Allman et al, 1993). To estimate the
half-life of the naive B cell compartment, we adoptively transferred allotype-marked

splenic Bl-8hlgh B cells and followed their survival in wild-type recipients. Our estimate
of the half-life of naive B cells turned out to be approximately 90 days. The rate of
reduction of T-I memory B cells was similar to that of naive B l-8hrgh B cells, suggesting
that naive and T-I memory B cells have a similar lifespan.
We next compared the proliferative response of Bl-8hlgh B cells from NP-Ficoll
primed and naive mice to a range of NP-Ficoll doses after their adoptive transfer into
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naive recipients. W e found no difference in the sensitivity of B l-8hlgh naive and T-I
memory B cells to the lowest dose tested (1 pig). This approach, however, has inherent
caveats. First, adoptive transfer of B cells results in a low degree of non-specific
proliferation, obvious by a diffuse CFSE peak in unimmunized controls (Figure 6B).
This makes it unfeasible to test NP-Ficoll doses lower than 1 ug. Second, both primed
and naive B cells used in this experiment were of high affinity to antigen, which may not

reflect a physiologic scenario. Third, not all IgX+Bl-8hlgh B cells from primed mice might
have been memory B cells. Fourth, although splenic localization of T-I memory B cells
has not been yet determined, it is possible that adoptive transfer disrupts their proper
localization, which might give them an advantage in antigen contact.
Although we cannot conclude that T-I memory B cells are more sensitive to T-I
type II antigens than naive B cells of the same affinity, T-I memory B cells might be
more sensitive than naive B cells to stimulation by T-D antigens. This is suggested by
the studies, in which NP-Ficoll primed mice responded to a very low dose of NP-CGG
provided without any adjuvant, whereas naive mice did not (Maizels et al, 1988).
Furthermore, human memory B cells are uniquely responsive to T-I type I stimuli ex vivo
(Bernasconi et al, 2002), although T-I versus T-D origin of human memory B cells used
in those experiments was not known.

T-I memory B cell selection based on BCR affinity
Burnet's theory predicts selection of clones of higher affinity to antigen during the
immune response. Based on the competition assay between adoptively transferred Bl-

8high and Bl-8lovv B cells with a 40-fold difference in affinity to NP, Shih et al. sugges
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that this selection occurs at the stage of B cell activation in response to NP-Ficoll (Shih et
al, 2002). However, in contrast to the dominance of the VH 186.2 heavy chain-expressing
clones after NP-CGG immunization (Cumano and Rajewsky, 1985), NP-Ficoll
immunization results in a heterogeneous collection of NP-specific hybridoma clones

(Maizels and Bothwell, 1985), reflecting lack of selection at the stage of B cell activatio
by NP-Ficoll in wild-type mice.
Here we tested the effect of BCR affinity on the development of T-I memory B

cells. Bl-8low B cells, adoptively transferred into wild-type recipients, did not develop t
T-I memory B cell compartment, although they responded to NP-Ficoll immunization
and formed both T-I GCs and plasma cells. However, B l-8low B cells were capable of
forming the memory compartment in PKCp' recipients, whose own B cells do not
respond productively to T-I type II antigens (Leitges et al., 1996). Our data suggest that
BCR affinity-based competition occurs during the establishment of the T-I memory B
cell compartment rather than at the stage of B cell activation and are in agreement with
findings by Maizels and Bothwell mentioned above.
Analysis of hybridomas derived from wild-type mice revealed that reimmunization of NP-Ficoll primed mice resulted in a different composition of the NPspecific hybridoma repertoire compared with that after primary NP-Ficoll immunization.
Remarkably, clones in the secondary repertoire were of higher affinity than in the
primary repertoire, but did not contain somatic mutations (Maizels et al., 1988). These

data are consistent with our findings that Bl-8low clones are excluded from the long-lived
T-I memory B cell compartment in the competitive environment of wild-type recipients,

which would result in the repertoire shift towards higher affinity clones in the absence o
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somatic mutation. It remains to be determined h o w the selection of higher affinity clones
in the T-I memory B cell compartment is enforced at the molecular level.
Our data implicate BCR-antigen interaction in the establishment or the survival of
the long-lived T-I memory B cell compartment. It has been reported, however, that
memory B cells derived from T-D responses do not require immunizing antigen for
survival (Maruyama et al, 2000). A different outcome of our studies may reflect the fact
that we focused on an early stage of memory B cell development, whereas Maruyama et
al. tested antigen requirement for memory B cell survival starting 6-8 weeks after
immunization. It cannot be ruled out, however, that T-I and T-D memory B cells differ
in their requirement for interaction with an immunizing antigen.

The role of Blimp-1 in T-I type II B cell response
Blimp-1 is a transcription factor necessary for antibody production. T-D responses have
been thoroughly analyzed in Blimp-1 knock-out mice, which lack plasma cell formation
and generate enlarged GCs (Shapiro-Shelef et al, 2003). It has been speculated that
oversized GCs are due to the accumulation of cells whose differentiation to plasma cells
is blocked in the absence of Blimp-1 (McHeyzer-Williams and McHeyzer-Williams,
2005).
Here we examined the role of Blimp-1 in the T-I type II B cell response. We

found that conditional disruption of Blimp-1 in B cells did not affect B cell activation i
response to NP-Ficoll immunization, but caused a significant reduction in the number of
plasma cells and an increase in the number of GC B cells, which is analogous to the
effect of Blimp-1 disruption on the T-D response. Since plasma cell formation precedes
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the G C formation during T-I type II responses, our findings suggest that Blimp-1 has two
independent functions in B cells: allowing plasma cell development and limiting the GC
reaction.
In our experiments Blimp-1 deficiency resulted in a lower number of T-I memory
B cells detected by the BrdU pulse-chase strategy. It is unclear whether Blimp-1deficient B cells simply proliferate longer than wild-type B cells and thus lose the BrdU
label or whether Blimp-1 deficiency genuinely affects T-I memory B cell development or
survival. T-I memory B cells do not express Blimp-1 and are not derived from Blimp-1
expressing precursors. Thus, Blimp-1 is unlikely to play a direct role in T-I memory B
cell development.
It is possible that Blimp-1 requirement for T-I memory B cell development, if

any, is indirect—i.e., due to the absence of antibodies or plasma cell-derived cytokines i
Blimp-1-deficient mice. Interestingly, B220" T-D memory B cells, which do not express
Blimp-1 (McHeyzer-Williams and McHeyzer-Williams, 2005), are absent in Blimp-1deficient mice (Shapiro-Shelef et al, 2003) and thus may have a similar indirect
requirement of Blimp-1 for their development or survival. The involvement of antibodies
of secondary isotypes in T-I memory B cell formation can be ruled out, since we were
able to detect BrdU-labeled T-I memory B cells in AID"'" mice, deficient in class switch
recombination (Muramatsu et al, 2000). It remains to be tested whether IgM antibodies
are required for the development of T-I and B220" T-D memory B cells, and if so,
whether they act through complement fixation and the engagement of complement
receptors or through the engagement of Fca/uR.
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IgG-mediated suppression
T-I memory B cells do not respond to secondary immunization with T-I type II antigens
in the presence of antigen-specific IgG antibodies generated during the primary immune
response. Similarly, naive B cells do not respond to T-I type II antigens in the presence
of passively transferred antigen-specific IgG antibodies. The presence of IgG, however,
does not preclude reactivation of memory B cells by T-D or T-I type I antigens
(Hosokawa, 1979; Zhang et al, 1988), suggesting that the properties of T-I type II
antigens make them the target for IgG-mediated suppression.
Although the phenomenon of IgG-mediated suppression of primary responses was
known before, the physiologic relevance of regulation of primary B cell responses by
passively transferred immune serum was uncertain, because antigen-specific antibodies
normally appear only after a productive B cell response. Our findings underscore a
physiologic regulatory function for IgG-mediated suppression. Due to their poor
biodegradability, T-I type II antigens, including synthetic and native bacterial
polysaccharides, are retained in the organism for long periods (Humphrey, 1981). The
existence of an expanded and long-lived pool of memory B cells capable of responding to
such persistent antigens necessitates a suppressive mechanism to prevent their continuous
reactivation leading to antibody overproduction. Antigen-specific IgG, a product of the
immune response, serves this important negative feedback regulation, thereby
maintaining humoral homeostasis.
The mechanism of IgG-mediated suppression has not been yet elucidated. It has
been reported that anti-NP antibodies suppress the response both against NP and its
carrier, sheep red blood cells, but not against co-injected unhaptenated horse red blood
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cells (Briiggemann and Rajewsky, 1982). Although this observation could rule out a
hypothesis that IgG-mediated suppression is due to epitope masking, it was argued that
haptens might block the access of B cells to the carrier (Heyman, 1993). Here we
demonstrate that when two non-crossreacting epitopes (NP and TNP) are coupled to the
same T-I type II carrier molecule (Ficoll), and thus should be equally accessible to B
cells, antibodies specific to one of the epitopes suppress the immune response against

both. It is therefore likely that an Fc portion of IgG antibodies is involved in suppressi
However, known Fey receptors do not appear to be involved in the suppression of
primary (Karlsson et al, 1999; Karlsson et al., 2001) or secondary T-I type II responses.

Implications for polysaccharide vaccines
We show that T-I type II responses, induced by a model polysaccharide antigen NPFicoll or bacteria, generate memory B cells. Several polysaccharide vaccines have been
developed, e.g. Pneumovax and Menomune, which combine purified capsule
polysaccharides from a number of S. pneumoniae and N. meningitidis strains,
respectively, to induce long-term humoral protection against these pathogens in adult
humans. Based on our findings in mice, we speculate that polysaccharide vaccines may
elicit memory B cells in humans. It remains to be tested to what extent memory B cells
contribute to long-term antibody production against poorly metabolized polysaccharide
antigens under the regulation of IgG-mediated suppression, and whether by slowly
replenishing the plasma cell pool, T-I memory B cells extend the effectiveness of
polysaccharide vaccines.
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